Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients

AIDS

Volumn 13, Issue 1, 1999, Pages 49-55

  Tascini, Carlo ^a   Vecchiarelli, Anna ^a   Preziosi, Roberta ^a   Francisci, Daniela ^b   Bistoni, Francesco ^a   Baldelli, Franco ^b  

^a Microbiology Section   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cellular factors; Cytokines; Fungal disease; Macrophage; Therapy

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; FLUCONAZOLE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUPEROXIDE; ZYMOSAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCOSIS; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FLOW CYTOMETRY; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIFUNGAL AGENTS; CELLS, CULTURED; CRYPTOCOCCUS NEOFORMANS; DRUG SYNERGISM; FLUCONAZOLE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; MONOCYTES; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033026953     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199901140-00007     Document Type: Article

References (29)

1. 1. Chuck SL, Sande MA: Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989, 321:794-799.
2. 2. Saag MS, Powderly WG, Cloud WG, et al.: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992, 326:793-798.
3. 3. Casadevall A, Spitzer D, Webb D, Rinaldi CU: Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother 1992, 37:1383-1386.
4. 4. Casadevall A: Cryptococcosis: the case of immunotherapy. Cliniguide Fungal Infect 1993, 4:1-5.
5. 5. Berry AJ, Rinaldi MG, Graybill JR: Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother 1992, 36:690-692.
6. 6. Haubrich RH, Haghigat D, Bozzette SA, Tilies J, McCutchan JA: High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J Infect Dis 1994, 170:238-242.
7. 7. Polak A: Combination therapy for systemic mycoses. Infection 1989, 17:203-209.
8. 8. Nguyen MH, Barchiesi F, McGough DA, Yu VL, Rinaldi MG: In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother 1995, 39:1691-1695.
9. 9. Coker, RJ, Viviani M, Gazzard BG, et al.: Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 1993, 7:829-835.
10. 10. Dromer F, Charreire J: Improved amphotericin B activity by a monoclonal anti-Cryptococcus neoformans antibody: study during murine cryptococcosis and mechanisms of action. J Infect Dis 1991, 163:114-120.
11. 11. Mukherjee J, Scharff MD, Casadevall A: Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci USA 1993, 40:3636-3640.
12. 12. Devi SJ, Schneerson R, Egan W, et al.: Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun 1991, 59:3800-3807.
13. 13. Miller MF, Mitchell TG: Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun 1991, 59:24-28.
14. 14. Pauza CD: HIV persistence in monocytes leads to pathogenesis and AIDS. Cell Immunol 1988, 112:414-424.
15. 15. Bender BS, Davison BL, Kline R, Brown C, Quinn TS: Role of the mononuclear phagocyte system in the immunopathogenesis of human immundeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis 1988, 10:1142-1154.
16. 16. Harrison TS, Kornfeld H, Levitz SM: The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes. J Infect Dis 1995, 172:665-671.
17. 17. Roilides E, Holmes E, Blake C, Pizzo PA, Walsh TJ: Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus infected children against Aspergillus fumigatus. J Infect Dis 1993, 168:1562-1565.
18. 18. Nassar F, Brummer E, Stevens DA: Effects of in vivo macrophage colony-stimulating factor on fungistasis of broncoalveolar and peritoneal macrophages against Cryptococcus neoformans. Antimicrob Agents Chemother 1994, 38:2162-2164.
19. 19. Nassar F, Brummer E, Stevens DA: Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing. Cell Immunol 1995, 164:113-118.
20. 20. Brummer E, Nassar F, Stevens DA. Effect of macrophage colony stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing. Antimicrob Agents Chemother 1994, 38:2158-2161.
21. 21. Chen GH, Curtis JL, Mody CH, Christensen PJ, Amstrong LR, Toews GB: Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol 1994, 152:724-734.
22. 22. Espinel-Ingroff A, Kish CW, Kerkering TM, et al.: Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1992, 30:3138-3145.
23. 23. Collins HL, Brancroft GJ: Cytokine enhancement of complement-dependent phagocytosis by macrophages synergy of tumor necrosis factor-α and granulocyte-macrophage colony stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 1992, 22:1447-1454.
24. 24. Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA, Walsh TJ: Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J Infect Dis 1994, 170:894-899.
25. 25. Denning DW, Armstrong RW, Lewis BH, Stevens DA: Elevated cerebrospinal fluid pressure in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991, 91:267-272.
26. 26. Washburn RG, Tuazon CU, Bennett JR: Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome. J Infect Dis 1985, 151:565-566.
27. 27. Chaturvedi S, Frame P, Newman SL: Macrophages from human immunodeficiency virus-positive persons are defective in host defence against Histoplasma capsulatum. J Infect Dis 1995, 171:320-327.
28. 28. Muller F, Rollay H, Froland SS: Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects. Clin Exp Immunol 1990, 82:10-15.
29. 29. Vecchiarelli A, Monari C, Baldelli F, et al.: Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J Infect Dis 1995, 171:1448-1454.